SMI 8'515 0.1%  Dow 20'624 0.0%  Nikkei 19'328 0.4%  Euro 1.0644 0.0% 
SPI 9'326 0.2%  EStoxx50 3'312 0.1%  Gold 1'234 -1.3%  Dollar 1.0057 0.3% 
DAX 11'828 0.6%  FTSE100 7'300 0.0%  Öl 56.2 0.1%  Pfund 1.2527 0.2% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

08.12.16 Biomarin Pharmaceutical Buy Gabelli & Co
03.11.16 Biomarin Pharmaceutical Buy Deutsche Bank AG
08.04.16 Biomarin Pharmaceutical Outperform BMO Capital Markets
08.03.16 Biomarin Pharmaceutical Outperform Robert W. Baird & Co. Incorporated
03.03.16 Biomarin Pharmaceutical Buy Stifel, Nicolaus & Co., Inc.
29.02.16 Biomarin Pharmaceutical Neutral Wedbush Morgan Securities Inc.
26.02.16 Biomarin Pharmaceutical Outperform RBC Capital Markets
25.11.15 Biomarin Pharmaceutical Perform Oppenheimer & Co. Inc.
08.07.15 Biomarin Pharmaceutical Outperform RBC Capital Markets
19.06.15 Biomarin Pharmaceutical Neutral Robert W. Baird & Co. Incorporated
18.06.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
18.06.15 Biomarin Pharmaceutical Buy Canaccord Adams
18.06.15 Biomarin Pharmaceutical Outperform RBC Capital Markets
05.06.15 Biomarin Pharmaceutical overweight Barclays Capital
27.03.15 Biomarin Pharmaceutical Buy UBS AG
27.03.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
Seite: 1 | 2

Eintrag hinzufügen

Aktuelle Aktienanalysen
20.02.17 Essilor International Neutral Goldman Sachs Group Inc.
20.02.17 Carl Zeiss Meditec kaufen Norddeutsche Landesbank (Nord/LB)
20.02.17 HSBC Neutral Goldman Sachs Group Inc.
20.02.17 TAKKT kaufen DZ BANK
20.02.17 Lloyds Banking Group Sell Goldman Sachs Group Inc.
20.02.17 Unilever Sell Goldman Sachs Group Inc.
20.02.17 Barclays Neutral Goldman Sachs Group Inc.
20.02.17 Unilever Sell Goldman Sachs Group Inc.
20.02.17 Volkswagen vz Conviction Buy List Goldman Sachs Group Inc.
20.02.17 bet-at-homecom Neutral Oddo Seydler Bank AG
20.02.17 Dialog Semiconductor overweight Morgan Stanley
20.02.17 Alstom neutral Morgan Stanley
20.02.17 WCM Beteiligungs- und Grundbesitz-AG buy Oddo Seydler Bank AG
20.02.17 CEWE Stiftung & Neutral Oddo Seydler Bank AG
20.02.17 TAG Immobilien Neutral Oddo Seydler Bank AG
20.02.17 Deutsche Euroshop Neutral Oddo Seydler Bank AG
20.02.17 Drillisch Neutral Oddo Seydler Bank AG
20.02.17 Infineon Technologies Halten Independent Research GmbH
20.02.17 Software buy Oddo Seydler Bank AG
20.02.17 innogy Underweight Morgan Stanley
20.02.17 RWE overweight Morgan Stanley
20.02.17 BT Group Neutral UBS AG
20.02.17 Uniper overweight Morgan Stanley
20.02.17 Allianz Underweight Barclays Capital
20.02.17 EON Equal-Weight Morgan Stanley
20.02.17 Barclays buy Deutsche Bank AG
20.02.17 ING Group buy Deutsche Bank AG
20.02.17 BNP Paribas buy Deutsche Bank AG
20.02.17 Allianz buy Oddo Seydler Bank AG
20.02.17 Covestro Equal weight Barclays Capital
20.02.17 Allianz Underweight Barclays Capital
20.02.17 CTS Eventim buy Commerzbank AG
20.02.17 Covestro buy Commerzbank AG
20.02.17 AstraZeneca Neutral JP Morgan Chase & Co.
20.02.17 Allianz overweight JP Morgan Chase & Co.
20.02.17 Peugeot overweight JP Morgan Chase & Co.
20.02.17 Allianz Hold Société Générale Group S.A. (SG)
20.02.17 Air France-KLM buy Citigroup Corp.
20.02.17 Bertrandt Hold Warburg Research
20.02.17 FUCHS PETROLUB buy Warburg Research
20.02.17 BP overweight JP Morgan Chase & Co.
20.02.17 Ströer buy Hauck & Aufhäuser Privatbankiers KGaA
20.02.17 Bertrandt buy Hauck & Aufhäuser Privatbankiers KGaA
20.02.17 Allianz buy Kepler Cheuvreux
20.02.17 HSBC Neutral JP Morgan Chase & Co.
20.02.17 Talanx Neutral Oddo Seydler Bank AG
20.02.17 Groupe Danone Hold Baader Bank
20.02.17 Covestro Sell Baader Bank
20.02.17 Allianz buy Baader Bank
20.02.17 Nokia buy Goldman Sachs Group Inc.